Medicare Enrolled
Dr. Julia Kaplun, M.D.
Optician · Suffern, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kaplun from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kaplun?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kaplun
Dr. Julia Kaplun is an optician specialist in Suffern, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kaplun performed 12,843 Medicare services across 3,863 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kaplun received a total of $5,514 from 39 pharmaceutical and/or device companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kaplun is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NY
$5,514 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,843
Medicare services
Top 5% in NY for optician
3,863
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~642 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,821 | $18 | $35 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
645 | $8 | $10 |
| Total T3 thyroid hormone test A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels. |
590 | $14 | $35 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
587 | $9 | $35 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
584 | $16 | $50 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
561 | $4 | $10 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
555 | $10 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
521 | $107 | $250 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
517 | $9 | $30 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
494 | $8 | $50 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
476 | $13 | $50 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
457 | $29 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
180 | $77 | $175 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
154 | $73 | $130 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
106 | $13 | $50 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
99 | $15 | $25 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
65 | $162 | $350 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
61 | $103 | $250 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
58 | $34 | $45 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
54 | $198 | $350 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
47 | $28 | $100 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
35 | $40 | $100 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
30 | $73 | $150 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
25 | $13 | $35 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $111 | $350 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
24 | $69 | $250 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $169 | $350 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
19 | $4 | $10 |
| New patient office visit, complex (60-74 min) | 17 | $188 | $450 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
14 | $47 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,514
Total received (2018-2024)
Avg $788/year across 7 years
Top 22% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
269
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,714 (85.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$800 (14.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,139
2023
$1,144
2022
$1,032
2021
$368
2020
$625
2019
$425
2018
$780
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$240
Novo Nordisk Inc
$224
Mannkind Corporation
$134
Antares Pharma, Inc.
$62
PFIZER INC.
$56
SANOFI-AVENTIS U.S. LLC
$54
Xeris Pharmaceuticals, Inc.
$49
IBSA Pharma Inc.
$44
Radius Health, Inc.
$42
Amgen Inc.
$41
Abbott Laboratories
$37
GlaxoSmithKline, LLC.
$24
Insulet Corporation
$23
Bayer Healthcare Pharmaceuticals Inc.
$21
Medtronic, Inc.
$19
ABBVIE INC.
$19
RGH Enterprises LLC
$17
Amneal Pharmaceuticals LLC
$17
Chiesi USA, Inc.
$16
Top 3 companies account for 52.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,072
Tandem Diabetes Care, Inc.
$800
Lilly USA, LLC
$461
Amgen Inc.
$370
Corcept Therapeutics
$289
Abbott Laboratories
$251
Dexcom, Inc.
$210
Mannkind Corporation
$168
Insulet Corporation
$155
AstraZeneca Pharmaceuticals LP
$139
Boehringer Ingelheim Pharmaceuticals, Inc.
$139
AbbVie Inc.
$127
Bayer Healthcare Pharmaceuticals Inc.
$125
Medtronic MiniMed, Inc.
$102
IBSA Pharma Inc.
$96
Embecta Corp.
$92
MannKind Corporation
$78
SANOFI-AVENTIS U.S. LLC
$77
GlaxoSmithKline, LLC.
$75
Radius Health, Inc.
$73
PFIZER INC.
$69
Antares Pharma, Inc.
$62
ABBVIE INC.
$57
Amneal Pharmaceuticals LLC
$54
Xeris Pharmaceuticals, Inc.
$49
Becton, Dickinson and Company
$39
Horizon Therapeutics plc
$35
Bayer HealthCare Pharmaceuticals Inc.
$34
Medtronic, Inc.
$32
Azurity Pharmaceuticals, Inc.
$32
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$25
Merck Sharp & Dohme Corporation
$24
RGH Enterprises LLC
$17
Chiesi USA, Inc.
$16
VIVUS, Inc.
$16
Supernus Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme LLC
$15
Shire North American Group Inc
$13
Valeritas, Inc.
$13
Top 3 companies account for 42.3% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Adthyza · BAQSIMI · BD Nano 2nd Gen Pen Needle · CYCLOSET · DEXCOM G6 CGM SYSTEM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · JANUVIA · JARDIANCE · Kerendia · Korlym · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA (PARATHYROID HORMONE) · Omnipod · Ozempic · PREVNAR - 13 · PREVNAR 20 · Prolia · QSYMIA · RECORLEV · Rybelsus · SHINGRIX · SOMAVERT · STEGLATRO · SYNTHROID · Saxenda · Sogroya · TEPEZZA · TZIELD · Tirosint · Tymlos · UNITHROID · V-GO · Wegovy · XYOSTED · ZEPBOUND · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
3,074
Per 100K population
907.0
County median income
$110,631
Nearest hospital
GOOD SAMARITAN HOSPITAL OF SUFFERN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kaplun is a mixed practice specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kaplun experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Kaplun performed 5,821 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kaplun receive payments from pharmaceutical companies?
Yes. Dr. Kaplun received a total of $5,514 from 39 companies across 269 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kaplun's costs compare to other opticians in Suffern?
Dr. Kaplun's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kaplun) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Suffern
Browse opticians in Suffern ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Tandem Diabetes Care, Inc. Payments to Doctors
See all physicians who received payments from Tandem Diabetes Care, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology